These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16610368)

  • 1. Chemical chaperones: mechanisms of action and potential use.
    Papp E; Csermely P
    Handb Exp Pharmacol; 2006; (172):405-16. PubMed ID: 16610368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological chaperones: a new twist on receptor folding.
    Morello JP; Petäjä-Repo UE; Bichet DG; Bouvier M
    Trends Pharmacol Sci; 2000 Dec; 21(12):466-9. PubMed ID: 11121835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-Generation Pharmacological Chaperones: Beyond Inhibitors.
    Tran ML; Génisson Y; Ballereau S; Dehoux C
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32660097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical chaperones mitigate experimental asthma by attenuating endoplasmic reticulum stress.
    Makhija L; Krishnan V; Rehman R; Chakraborty S; Maity S; Mabalirajan U; Chakraborty K; Ghosh B; Agrawal A
    Am J Respir Cell Mol Biol; 2014 May; 50(5):923-31. PubMed ID: 24299608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological chaperones: potential treatment for conformational diseases.
    Bernier V; Lagacé M; Bichet DG; Bouvier M
    Trends Endocrinol Metab; 2004 Jul; 15(5):222-8. PubMed ID: 15223052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking.
    Perlmutter DH
    Pediatr Res; 2002 Dec; 52(6):832-6. PubMed ID: 12438657
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors.
    Mouillac B; Mendre C
    Handb Exp Pharmacol; 2018; 245():63-83. PubMed ID: 28939971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
    Brown CR; Hong-Brown LQ; Biwersi J; Verkman AS; Welch WJ
    Cell Stress Chaperones; 1996 Jun; 1(2):117-25. PubMed ID: 9222597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis.
    Yam GH; Gaplovska-Kysela K; Zuber C; Roth J
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1683-90. PubMed ID: 17389500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the potency of various low molecular weight chemical chaperones to prevent protein aggregation.
    Upagupta C; Carlisle RE; Dickhout JG
    Biochem Biophys Res Commun; 2017 Apr; 486(1):163-170. PubMed ID: 28285140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical chaperones interfere with the formation of scrapie prion protein.
    Tatzelt J; Prusiner SB; Welch WJ
    EMBO J; 1996 Dec; 15(23):6363-73. PubMed ID: 8978663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency.
    Burrows JA; Willis LK; Perlmutter DH
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1796-801. PubMed ID: 10677536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
    Tao YX; Conn PM
    Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical and pharmacological chaperones: application for recombinant protein production and protein folding diseases.
    Rajan RS; Tsumoto K; Tokunaga M; Tokunaga H; Kita Y; Arakawa T
    Curr Med Chem; 2011; 18(1):1-15. PubMed ID: 21110818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic potential of chemical chaperones in protein folding diseases.
    Cortez L; Sim V
    Prion; 2014; 8(2):197-202. PubMed ID: 24818993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical chaperones enhance superantigen and conventional antigen presentation by HLA-DM-deficient as well as HLA-DM-sufficient antigen-presenting cells and enhance IgG2a production in vivo.
    Ghumman B; Bertram EM; Watts TH
    J Immunol; 1998 Oct; 161(7):3262-70. PubMed ID: 9759841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
    Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
    Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the activity of newly synthesized human phenylalanine hydroxylase mutant proteins by low-molecular-weight compounds.
    Nascimento C; Leandro J; Tavares de Almeida I; Leandro P
    Protein J; 2008 Sep; 27(6):392-400. PubMed ID: 18769885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical chaperones reduce aggregate formation and cell death caused by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.
    Yoshida H; Yoshizawa T; Shibasaki F; Shoji S; Kanazawa I
    Neurobiol Dis; 2002 Jul; 10(2):88-99. PubMed ID: 12127147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of chemical chaperones based on their effect on protein folding landscapes.
    Dandage R; Bandyopadhyay A; Jayaraj GG; Saxena K; Dalal V; Das A; Chakraborty K
    ACS Chem Biol; 2015 Mar; 10(3):813-20. PubMed ID: 25493352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.